Lux Capital has 22 tracked deals to Maveron's 23. Stage focus, check size, and sector fit compared side by side.
Lux Capital is a venture capital with 22 tracked deals. Maveron is an active investor with 23 tracked deals. Maveron shows 1 more tracked round than Lux Capital in this dataset, which is the clearest signal of deployment pace between the two. Sector focus diverges: Lux Capital concentrates on Aerospace Defense, Artificial Intelligence and Biotech and Maveron on generalist deals. Recent tracked names include Amca and Atrandi Biosciences for Lux Capital and Barkbus and Bend Health for Maveron.
Investors like Lux Capital · Investors like Maveron · Lux Capital co-investors · Full investor directory